NEW YORK (GenomeWeb) –Oxford Immunotec has sued Qiagen, Quest Diagnostics, and Laboratory Corporation of America for infringing patents underlying Oxford's T-SPOT TB test.

In a complaint filed this week in US District Court for the District of Massachusetts, Oxford alleged that Qiagen's QuantiFERON-TB Gold and QuantiFERON-TB Plus tuberculosis diagnostics use peptide antigens patented by Oxford.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.